Inventory restock in progress — products are available to reserve by pre-order.
    Peptide South AfricaPeptide South Africa
    Source-linked verification

    The report, the result and the label—in one place.

    Review the exact tests reported for each published sample or lot, open the independent lab source, and create a vial label whose QR returns to that same record.

    Exact report

    Task, sample or lot reference shown

    Reported results

    Only tests present in the source are listed

    Permanent QR path

    Short PSA verification URL per record

    Find a report

    Search by product, SKU, task number, sample reference or lot number.

    Public archive

    Published COAs

    The source note distinguishes a supplier sample report from a PSA-specific production lot.

    MOTS-C lab report Open report
    Sample MOTS-C 10mgTask #83567Supplier source report2025/10/21

    MOTS-C 10 mg

    RTT-MTC-10 · Janoshik Analytical

    Reported content
    11.42 mg
    Reported purity
    99.098%

    Scope note: This report identifies the submitted sample as MOTS-C 10mg and names Zztai Peptide Ltd. as the client. Its batch is reported as Unknown, so it verifies the published lab report—not a unique PSA vial or lot.

    Retatrutide lab report Open report
    Sample Retatrutide 10mgTask #61141Supplier source report2025/04/01

    Retatrutide 10 mg

    RTT-GGG-10 · Janoshik Analytical

    Reported content
    10.80 mg
    Reported purity
    99.060%

    Scope note: This report identifies the submitted sample as Retatrutide 10mg and names Zztai Peptide Ltd. as the client. Its batch is reported as Unknown, so it verifies the published lab report—not a unique PSA vial or lot.

    Tirzepatide lab report Open report
    Sample T120Task #164662Supplier source report2026/05/27

    Tirzepatide 20 mg

    SOURCE-T120-20 · Janoshik Analytical

    Reported content
    134.42 mg; 132.84 mg
    Reported purity
    99.867%; 99.899%

    Scope note: This report identifies the submitted sample as T120, names Zztai Peptide Ltd. as the client, and reports 134.42 mg and 132.84 mg. The submitted sample was 20 mg; the currently listed Tirzepatide is 10 mg per vial. Its batch is reported as Unknown, so it verifies the published source report—not a unique PSA vial or lot.

    Tesamorelin lab report Open report
    Sample TSM10Task #164644Supplier source report2026/05/27

    Tesamorelin 10 mg

    SOURCE-TSM10 · Janoshik Analytical

    Reported content
    12.95 mg; 12.27 mg
    Reported purity
    98.589%; 98.425%

    Scope note: This report identifies the submitted sample as TSM10 and names Zztai Peptide Ltd. as the client. The submitted sample was 10 mg; the PSA-listed product is 5 mg per vial. Its batch field is blank, so it verifies the published lab report—not a unique PSA vial or lot.

    Label studio

    Print the verified record onto the vial.

    Optimized for the Nelko P21 40 × 14 mm roll and Brother VC-500W 45 × 25 mm tape.

    Verified label studio

    COA-linked vial labels

    Every QR uses a short, PSA-owned verification path. For Nelko prints, create the QR natively in the app so image resizing cannot soften the code.

    QR → https://www.peptide-south-africa.com/v/m01

    Native export: 320 × 112 px · 40 × 14 mm

    Camera-safe Nelko workflow

    1. Tap Copy native QR link, then save or share the Nelko background.
    2. In the Nelko app, select the P21 40 × 14 mm label and import the background at 100%.
    3. Use Nelko's QR code tool, paste the copied link and place the native QR over the blank left square.
    4. Keep the QR black on white and as large as the left square allows. Do not add a border or other artwork around it.
    5. Use the darkest/highest-quality print setting. Scan the first label while it is still flat, then apply it with the QR centred on the visible face of the vial.

    If the flat label scans but the vial does not, the vial curvature—not the URL—is the failure point.